TMFGBudwell

George Budwell

TMFGBudwell’s Activity

Tue Jan 27

NL

Article

gbudwell published an article 9:55 AM

Bristol-Myers Squibb Co.'s Fourth Quarter Earnings Warn of a Tough Year Ahead

Bristol-Myers Squibb Co. reported its fourth quarter earnings Tuesday morning. Here's what investors need to know.

NL

Article

gbudwell published an article 8:27 AM

Pfizer Inc.'s Fourth-Quarter Earnings Hint at Big Things to Come

Pfizer Inc. reported its fourth-quarter earnings before the bell this morning. Here's what investors need to know going forward.

Sat Jan 17

NL

Article

gbudwell published an article 8:58 PM

Why Johnson & Johnson's Stock Could Crater in 2015

Johnson & Johnson is facing some serious threats to its top line this year. Here's what investors need to know going forward.

Fri Jan 16

NL

Article

gbudwell published an article 5:00 AM

Can AbbVie Inc. Overcome Humira’s Looming Patent Expiration?

AbbVie's most important product, Humira, will lose patent exclusivity in the U.S. in 2016. Should investors fear this upcoming event?

Wed Jan 14

NL

Article

gbudwell published an article 1:10 AM

These 3 Dividend Stocks Could Crush the Market in 2015

AbbVie, Amgen, and Pfizer are three dividend stocks that could crush the broader market this year. Here's why.

Mon Jan 12

NL

Article

gbudwell published an article 10:45 AM

Why Shares of Foundation Medicine, Inc. Skyrocketed Today

Shares of cancer diagnostic maker Foundation Medicine more than doubled Monday morning. Here's why.

NL

Article

gbudwell published an article 4:53 AM

Bristol-Myers Squibb's New Cancer Drug Hits the Mark: What's Next?

Bristol-Myers Squibb announced that its closely-watched cancer drug, Opdivo, achieved a significant clinical milestone. Here's what you need to know.

Wed Jan 7

NL

Article

gbudwell published an article 1:59 AM

Is Gilead Sciences Inc. Now a Takeover Target?

Gilead Sciences looks cheap based on its present valuation metrics and growth prospects going forward. Will a growth-starved big pharma decide to pursue a merger with this high flying biotech in 2015?

Tue Jan 6

NL

Article

gbudwell published an article 6:31 AM

Is AbbVie Inc. Ripe for a Buyout?

After failing to complete a buyout of Irish biopharma Shire, AbbVie was reported to be a potential takeover target. Is this top drugmaker an attractive acquisition target for growth-starved big pharma in 2015?

Mon Jan 5

NL

Article

gbudwell published an article 7:18 AM

Is Celgene Corporation a Takeover Target in 2015?

The pharmaceutical industry is expected to continue its widespread consolidation phase this year. Will Celgene be the next company to be bought out?

NL

Article

gbudwell published an article 1:00 AM

Does Pfizer Inc. Stock Offer a Market-Crushing Opportunity in 2015?

Pfizer's stock has languished for the better part of a decade now, failing to benefit from the broader bull market. With several key events on the horizon, this trend could change in a big way. Here's what investors need to know.

Sun Jan 4

NL

Article

gbudwell published an article 7:08 AM

Does AstraZeneca PLC Stock Offer a Golden Opportunity in 2015?

AstraZeneca would appear to be set to have a slow 2015. But that doesn't mean investors should sleep on this stock. Here's why.

NL

Article

gbudwell published an article 1:58 AM

1 Amazing Chart Shows Why Gilead Sciences, Inc.'s Stock Still Belongs in Your Portfolio

Gilead Sciences saw its shares drop by close to 20% after its chief competitor, AbbVie, delivered a major blow to its hepatitis C franchise. A single chart, though, shows why selling this top biotech stock is probably a huge mistake.

Fri Jan 2

NL

Article

gbudwell published an article 3:18 AM

3 Clinical-Stage Biotech Stocks with Explosive Upside Potential in 2015

Clinical-stage biotechs tend to bubble to the top of the list of best performing healthcare stocks. Here are three names to watch in 2015 and beyond.

Mon Dec 29

NL

Article

gbudwell published an article 8:24 PM

Growth Stocks 2015: 3 Companies With Room to Run

AbbVie, Celgene, and Gilead Sciences are three growth stocks with room to run in 2015 and beyond. Here's why.

NL

Article

gbudwell published an article 3:12 AM

Does This Dividend Stock Belong in Your Portfolio in 2015?

Teva Pharmaceutical Industries is a favorite name among income investors. With steep headwinds facing the company in 2015, though, its dividend might be at risk. Here's what investors need to know.

Sat Dec 27

NL

Article

gbudwell published an article 11:11 PM

Is 1 Drug Really Outselling Legalized Marijuana?

Legalized marijuana is reportedly the fastest growing industry in the U.S. right now. Even so, this single drug vastly outsells the entire industry -- and probably will for years to come.

NL

Article

gbudwell published an article 3:35 AM

Billionaires Are Gobbling Up These Stocks Right Now

Billionaires took out huge positions in AbbVie, Celladon Corp., and Kite Pharma in the third quarter. Should you follow in their giant footsteps?

Fri Dec 26

NL

Article

gbudwell published an article 6:34 AM

Pharma Stocks Could Be in Deep Trouble in 2015. Here's Why.

Costly new drugs have driven pharma stock prices to all-time highs over the last two years. Here's why this trend might come to a screeching halt.

NL

Article

gbudwell published an article 2:03 AM

Is GlaxoSmithKline plc's Monster Dividend Worth the Risk?

GlaxoSmithKline has had a rotten 2014, leading to a dramatic downturn in its share price. Can this high-yielding dividend stock rebound in 2015?

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating < 20
Player Rank 0 out of 75108
Score 0.00
Score Change Today 0
Accuracy 0.00%
Active Picks 0
Total Picks 5
Best Pick RXII (+9.56)
Worst Pick IMUC (-28.72)
Average Score per Pick 0.00
Charms Earned 0
Highest Rated Favorite No Favorites Selected
Go to TMFGBudwell’s CAPS page

Boards Stats & Trivia

Board Posts 0
Recs Received 0
People who have rec'd these posts 0
Recs to Posts Ratio (last 30 days) N/A
Threads Started 0
Threads Started Percentage 0.00 %
Most Frequent Board N/A
Very First Post N/A
Percentage of Posts Rec'd 100.00 %
Show TMFGBudwell’s 10 Latest Posts